MENU
BIIB
AS OF
Nov 19, 04:59 PM (EDT)
Price
$167.94
Change
-$0.89 (-0.53%)
Capitalization
24.64B
71 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
BIIB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Biogen (BIIB) Ownership - Who owns Biogen?

Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7570
Web
https://www.biogen.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
24.64B
P/E Ratio
15.31
Total Cash
3.96B
Projected Growth
4.35
Total Debt
6.59B
Revenue
10.07B
Risk (Beta)
0.61
Dividend Yield
N/A
Total Cash/Share
27.00
Total Debt/Equity
6.50
Revenue/Share
68.71 USD as % of share price

Fundamentals

BIIB
Capitalization
24.6B
P/E Ratio
15.31
Risk (Beta)
0.61
Dividend Yield
N/A
Total Cash
3.96B
Total Cash/Share
27.00
Total Debt
6.59B
Total Debt/Equity
6.50
Projected Growth (PEG Ratio)
4.35
Revenue/Share (as % of the share price)
68.71%
Revenue
10.1B
ROE
N/A
Book Value
18.2B
P/B Ratio
1.35
Cash Flow
N/A
Earnings
10.99
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
2.72
Current Revenue Per Employee
333293.88
Dividends Per Share - Security
N/A
EBITDA
2.93B
Float
N/A
Float - Current
N/A
Gross Income Margin
73.39
Revenue To Assets
5.59
Shares Held By Institutions
48.2B
Shares Outstanding - Current
147M
Total Liabilities
11B
Total Volume MTD
N/A
Value
-1
Gain YTD
10.404
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BIIB
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BIIB showed earnings on October 30, 2025. You can read more about the earnings report here.
View AI-Driven Trading for BIIB
A.I. Advisor
published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7570
Web
https://www.biogen.com